The National Eczema Association makes an impact by providing grants for key eczema research!

The National Eczema Association (NEA) research program offers grants to established and new investigators in the field. The research projects range from important studies on itch, to genome wide studies, and the objective severity assessment of atopic dermatitis/eczema. This research ultimately benefits patients with eczema by providing much needed basic research data to scientists, physicians and pharmaceutical companies.

Research funding expenditures are supported by the generous donations of our individual donors and corporate partners:

2003 — $0
2004 — $63,000
2005 — $83,000
2006 — $64,000
2007 — $115,000
2008 — $53,000

Investigators interested in applying for a National Eczema Association research grant are welcome to contact the NEA office.

• Genome-wide Analysis of Atopic Dermatitis
• Patrick Brown, MD PhD and Annika Saaf, PhD
  Beckman Center for Molecular and Genetic Medicine
  Stanford University Medical Center
  
  
• Final Report
  
  
• Topical Calcineurin Inhibitors for Atopic Dermatitis: Balancing Clinical Benefit and Possible Risks
• Abrar A. Qureshi, MD, MPH and Michael A. Fisher, MD, MS
  Brigham and Women’s Hospital
  Harvard Medical School
  
  
• Final Report
  
  
• Do Alopecia Areata and Atopic Dermatitis share HLA alleles and cytokine profiles?
• Nazila Barahmani, MD
  Anderson Cancer Center
  Houston, TX
  
  
• Final Report
  
  
• The Central Processing of Pruritus in Atopic Dermatitis using Arterial Spin Labeling Functional MRI
• Gil Yospovitch, MD and Robert Coghill, PhD
  Department of Neurobiology and Anatomy
  Wake Forest University
  
  
• Final Report
  
  
• The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients
• Gil Yospovitch, MD and Robert Coghill, PhD
  Department of Neurobiology and Anatomy
  Wake Forest University
  
  
• Final Report: PENDING
  
  
• Why subjects with atopic dermatitis (AD), as compared to non-atopic, healthy controls, have a barrier defect in the skin that makes them more susceptible to skin infections.
• Anna De Benedetto, MD and, Lisa A. Beck MD
  Department of Dermatology
  University of Rochester (NY)
  
  
• Final Report
  
  
• Cathelicidin antimicrobial peptides influence mast cell granule composition and release: control of itch by the innate immune system.
• Anna Di Nardo, M.D., Ph.D.
  Department of Dermatology
  University of California, San Diego
  
  
• Final Report
  
  
• The Role of the Skin Barrier in the Development and Prevention of Atopic Dermatitis
• Eric Simpson, MD
  Department of Dermatology
  Oregon Health & Science University
  
  
• Final Report: PENDING